Location

Rochester, Minnesota

Summary

Clinical Studies in Diabetes and Metabolism

The primary interest of our laboratory during the last five years has been clinical research related to diabetes, obesity and nutrition.

In diabetes, we have completed studies investigating the use of a biguanide (Metformin) in the treatment of Type II diabetes mellitus and an aldose reductase inhibitor (Tolrestat) to prevent diabetic neuropathy. We have also explored insulin analogues in the treatment of Type I diabetes. Most recently, we have been working with an intermittent intravenous pulsatile insulin infusion program to prevent the progression of diabetic nephropathy.

In the area of obesity, we have developed, implemented and evaluated a state-of-the-art behaviorally based weight management program.

In the area of nutrition, our research has included investigating enteral formulas and their glycemic responses in diabetic volunteers and in assessing caloric expenditure in the morbidly obese.

In the future we will have separate studies using L-carnitine and aminoguanidine for the prevention of diabetic neuropathy and nephropathy, respectively, and will evaluate bariatric surgery as a long-term treatment modality for the morbidly obese.

Recent Publications

See my publications

Professional Details

Primary Appointment

  1. Endocrinology

Academic Rank

  1. Assistant Professor of Medicine

Education

  1. Fellow - Endocrinology Mayo Clinic in Rochester
  2. Fellow - Research Fellowship, Endocrinology Mayo Clinic in Rochester
  3. Resident - Medicine Mayo Clinic in Rochester
  4. Internship - Medicine Mayo Clinic in Rochester
  5. MD Boston University School of Medicine
  6. BA - Biology Boston University
.
BIO-00078352

Mayo Clinic Footer